Trial Profile
A Preference Evaluation of Nasonex Nasal Spray (Unscented) vs. Flonase Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary) ; Fluticasone propionate
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors Organon
- 22 Nov 2008 New trial record.